Synthesis, In Silico Analysis, and In Vitro Cytotoxic Activity of Novel Benzocamalexins
Biomolecules · 12.11.2026 · 16 (11) · 1651
DOI: 10.3390/biom16111651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 12.11.2026. Verfasst von Maria Bachvarova und 6 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Fund for Scientific Research of University of Plovdiv, Programme “Research, Innovation and Digitalisation for Smart Transformation”.
Abstract (Originalsprache)
Cancer treatment remains a major challenge in medicine due to high toxicity and drug resistance, motivating the application of novel selective cytotoxic agents based on natural compounds. In this study, ten novel benzocamalexin analogues 5a–e with variously substituted indoles were designed, synthesized, and evaluated for anticancer activity. An efficient two-step strategy was applied, involving regioselective α-amidoalkylation at C3 of indoles, followed by oxidative rearomatization of 2-(3-indolyl)-N-acylbenzothiazolines 4a–f. The use of the mild oxidant o-Chloranil in the second step enables the formation of target benzocamalexins (73–93% yield). In silico toxicological screening classified all compounds as non-mutagenic, with analogues 5b–e showing high predicted acute oral safety (LD50 = 2447.55–2486.05 mg/kg). In vitro MTT assays across human lung (A549), cervical (HeLa), and colorectal (LS180) adenocarcinoma cells, alongside normal fibroblasts (HFFC), demonstrated selective cytotoxicity. Thus, analogues 5b, 5c, and 5e displayed superior cytotoxic potency against cancer cells compared to benzocamalexin, while 4d, 5a, 5c, and 5d showed lower toxicity toward normal fibroblasts. Molecular docking with the aryl hydrocarbon receptor (AhR) predicted strong binding affinities for 5b–e (−10.1 to −10.3 kcal/mol). The AhR interaction for camalexin (−9.4 kcal/mol) and benzocamalexin (−10.0 kcal/mol) was recognized as a potential mechanism for their selective antitumour efficacy.
Förderung
- European Union
- Fund for Scientific Research of University of Plovdiv
- Programme “Research, Innovation and Digitalisation for Smart Transformation”
Zitieren
APA
Bachvarova, M., Stremski, Y., Statkova-Abeghe, S., Batsalova, T., Moten, D., Apostolova, D., & Dzhambazov, B. (2026). Synthesis, In Silico Analysis, and In Vitro Cytotoxic Activity of Novel Benzocamalexins. Biomolecules, 16(11), 1651. https://doi.org/10.3390/biom16111651
Vancouver
Bachvarova M, Stremski Y, Statkova-Abeghe S, Batsalova T, Moten D, Apostolova D, et al. Synthesis, In Silico Analysis, and In Vitro Cytotoxic Activity of Novel Benzocamalexins. Biomolecules. 2026;16(11):1651. doi:10.3390/biom16111651
BibTeX
@article{Bachvarova2026,
author = {Bachvarova, Maria and Stremski, Yordan and Statkova-Abeghe, Stela and Batsalova, Tsvetelina and Moten, Dzhemal and Apostolova, Desislava and Dzhambazov, Balik},
title = {Synthesis, In Silico Analysis, and In Vitro Cytotoxic Activity of Novel Benzocamalexins},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {11},
pages = {1651},
doi = {10.3390/biom16111651}
}
EUVIMED